Advanced Search

Acne-Like Disorders Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Thomas Jansen

    Thomas Jansen

    Department of Dermatology, Venereology and Allergology, University of Essen, Essen, Germany

  • Photo of Christos Zouboulis

    Christos Zouboulis

    Departments of Dermatology and Immunology, Dessau Medical Center, Dessau, Germany

Section Topics

  • » Acne vulgaris
  • » Acne-like disorders
  • » Rosacea
  • » Rosacea-like disorders

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

6
Could higher doses of isotretinoin reduce the frequency of treatment failure in patients with acne?

Coloe J, Du H, Morrell DS. J Am Acad Dermatol. 2011 Aug; 65(2):422-3

1 Evaluation, most recent by

Yolanda Helfrich and Hyuk Cha, University of Michigan, USA. F1000 Dermatology

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.